These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30999915)

  • 1. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
    Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
    Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
    PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
    Hoglund RM; Ruengweerayut R; Na-Bangchang K
    Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
    Ramharter M; Kurth FM; Bélard S; Bouyou-Akotet MK; Mamfoumbi MM; Agnandji ST; Missinou MA; Adegnika AA; Issifou S; Cambon N; Heidecker JL; Kombila M; Kremsner PG
    J Antimicrob Chemother; 2007 Nov; 60(5):1091-6. PubMed ID: 17884832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
    Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
    Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
    Leang R; Ros S; Duong S; Navaratnam V; Lim P; Ariey F; Kiechel JR; Ménard D; Taylor WR
    Malar J; 2013 Sep; 12():343. PubMed ID: 24060207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.
    Jullien V; Valecha N; Srivastava B; Sharma B; Kiechel JR
    Malar J; 2014 May; 13():187. PubMed ID: 24886117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
    Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
    Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of artesunate and amodiaquine in African children.
    Stepniewska K; Taylor W; Sirima SB; Ouedraogo EB; Ouedraogo A; Gansané A; Simpson JA; Morgan CC; White NJ; Kiechel JR
    Malar J; 2009 Aug; 8():200. PubMed ID: 19691851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
    Santelli AC; Ribeiro I; Daher A; Boulos M; Marchesini PB; dos Santos RL; Lucena MB; Magalhães I; Leon AP; Junger W; Ladislau JL
    Malar J; 2012 Aug; 11():286. PubMed ID: 22905900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria.
    Thuy le TD; Hung le N; Hung NC; Na-Bangchang K
    Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):205-12. PubMed ID: 17539268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
    Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
    Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.
    Saeheng T; Na-Bangchang K
    PLoS One; 2023; 18(2):e0282099. PubMed ID: 36821622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
    Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
    PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
    Reuter SE; Upton RN; Evans AM; Navaratnam V; Olliaro PL
    J Antimicrob Chemother; 2015 Mar; 70(3):868-76. PubMed ID: 25377567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
    Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
    PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
    Valecha N; Srivastava B; Dubhashi NG; Rao BH; Kumar A; Ghosh SK; Singh JP; Kiechel JR; Sharma B; Jullien V; Dash AP; Taylor WR; Anvikar AR
    J Vector Borne Dis; 2013 Dec; 50(4):258-64. PubMed ID: 24499847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
    Na-Bangchang K; Ruengweerayut R; Wernsdorfer WH
    Eur J Clin Pharmacol; 2011 Jul; 67(7):687-91. PubMed ID: 21556929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.